文献速递产科生殖医学母胎医学

公共资助辅助生殖技术对母婴结局的影响:前后对比研究

Effect of publicly funded assisted reproductive technology on maternal and infant outcomes: a pre- and post-comparison study.
PubMed 文献 · Hum Reprod · 2021-01-01

STUDY QUESTION: Does publicly funded assisted reproductive technology result in improved maternal and infant outcomes? SUMMARY ANSWER: Publicly funded ART in Quebec was associated with reduced risks of preeclampsia, cesarean delivery, preterm birth, low birth weight and other adv…

要点

  • 公共资助ART与子痫前期、剖宫产、早产、低出生体重风险降低相关
  • 排除多胎妊娠后,子痫前期和早产风险仍降低
  • 公共资助ART与妊娠期糖尿病风险增加相关

核心结论

  • 魁北克公共资助ART项目与子痫前期、剖宫产、早产、低出生体重等不良结局风险降低相关,但妊娠期糖尿病风险增加。

研究设计与样本

  • 采用对数二项回归模型估计风险比(RR)及95%置信区间,并调整母亲特征。

主要发现

  • 公共资助ART与重度孕产妇病率风险降低相关(RR 0.64,95% CI 0.50-0.83)。
  • 公共资助ART与子痫前期(RR 0.55,95% CI 0.44-0.68)、剖宫产(RR 0.83,95% CI 0.77-0.89)、早产(RR 0.67,95% CI 0.60-0.75)、低出生体重(RR 0.63,95% CI 0.55-0.72)风险降低相关。
  • 公共资助ART与重度新生儿病率(RR 0.75,95% CI 0.57-0.99)及新生儿重症监护病房入住(RR 0.65,95% CI 0.53-0.78)风险降低相关。
  • 排除多胎妊娠后,公共资助ART仍与子痫前期(RR 0.61,95% CI 0.48-0.79)和早产(RR 0.85,95% CI 0.73-0.99)风险降低相关。
  • 公共资助ART与妊娠期糖尿病风险增加相关。

临床怎么用

  • 公共资助ART项目鼓励单胚胎移植可能对多种母婴结局有实质性获益,超越预防多胎妊娠。

局限性

  • 缺乏ART类型、体外受精周期数及移植胚胎数的信息。
  • 缺乏体重指数、种族和吸烟数据,不能排除残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does publicly funded assisted reproductive technology result in improved maternal and infant outcomes? SUMMARY ANSWER: Publicly funded ART in Quebec was associated with reduced risks of preeclampsia, cesarean delivery, preterm birth, low birth weight and other adverse outcomes. WHAT IS KNOWN ALREADY: Publicly funded ART programs that provide free access to single embryo transfer are known to decrease the rate of multiple pregnancy, but the impact on other pregnancy outcomes is unknown. STUDY DESIGN, SIZE, DURATION: We conducted a pre- and post-comparison study of 597 416 pregnancies conceived between July 2008 and September 2015 in Quebec, Canada, a region where public funding of ART began in August 2010. PARTICIPANTS/MATERIALS, SETTING, METHODS: We included all pregnant women who conceived by ART (n = 14 309) or spontaneously (n = 583 107) and delivered a live or stillborn infant in hospitals of Quebec. The main exposure measure was conception before versus during the publicly funded ART program. Outcomes included measures of maternal and infant morbidity and mortality. We estimated risk ratios (RR) and 95% confidence intervals for the association of publicly funded ART with maternal and infant outcomes using log-binomial regression models adjusted for maternal characteristics. MAIN RESULTS AND THE ROLE OF CHANCE: In this study, 2638 pregnancies were conceived by ART before, and 11 671 were conceived by ART, during public funding. Compared with no public funding, ART funding was associated with reduced risks of severe maternal morbidity (RR 0.64, 95% CI 0.50-0.83), preeclampsia (RR 0.55, 95% CI 0.44-0.68), cesarean delivery (RR 0.83, 95% CI 0.77-0.89), preterm birth (RR 0.67, 95% CI 0.60-0.75), low birth weight (RR 0.63, 95% CI 0.55-0.72), severe neonatal morbidity (RR 0.75, 95% CI 0.57-0.99) and neonatal intensive care unit admission (RR 0.65, 95% CI 0.53-0.78). When multiple pregnancies were excluded, ART funding continued to be associated with a lower risk of preeclampsia (RR 0.61, 95% CI 0.48-0.79) and preterm birth (RR 0.85, 95% CI 0.73-0.99). However, ART funding was associated with increased risk of gestational diabetes. LIMITATIONS, REASONS FOR CAUTION: We had no information on the type of ART, number of in-vitro fertilization cycles or number of embryos transferred. We lacked data on body mass index, ethnicity and smoking and cannot rule out residual confounding. WIDER IMPLICATION OF THE FINDINGS: Our findings suggest that publicly funded ART programs that encourage single embryo transfer may have substantial benefits for a range of maternal and infant outcomes, beyond prevention of multiple births. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by grant 6D02363004 from the Public Health Agency of Canada. N.A. acknowledges a career award from the Fonds de recherche du Québec-Santé (34695). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Wei SQ, Bilodeau-Bertrand M, Lo E, et al. Effect of publicly funded assisted reproductive technology on maternal and infant outcomes: a pre- and post-comparison study. Hum Reprod. 2021. PMID: 33246340. doi:10.1093/humrep/deaa270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。